Evidence map›Paper›PMID 20823914›Full record

ArticleEuropean journal of human genetics : EJHG2011

Genomic analysis of partial 21q monosomies with variable phenotypes.

Elisha D O Roberson, Elizabeth Squibb Wohler, Julie E Hoover-Fong, Emily Lisi, Eric L Stevens, George H Thomas, Jay Leonard, Ada Hamosh, Jonathan Pevsner

Abstract read
In one paragraph

Article in European journal of human genetics : EJHG, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Generation of Monosomy 21q Human iPS Cells by CRISPR/Cas9-Mediated Interstitial Megabase Deletion.Genes to cells : devoted to molecular & cellular mechanisms · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. ATranslational pediatrics · 2021
    Article
  7. Article
  8. Psychiatric Disorders and Distal 21q Deletion-A Case Report.International journal of environmental research and public health · 2020
    Article
  9. Molecular cytogenetics · 2020
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Elisha D O RobersonProgram in Human Genetics, Johns Hopkins School of Medicine, Baltimore, MD, USA.
Elizabeth Squibb Wohler
Julie E Hoover-Fong
Emily Lisi
Eric L Stevens
George H Thomas
Jay Leonard
Ada Hamosh
Jonathan Pevsner

Funding

NICHD MENTAL RETARDATION RESEARCH CENTER CORE GRANTP30HD024061 · NICHD · KENNEDY KRIEGER CHILDRENS HOSPITAL · PI VALLE, DAVID · 1988 to 2013
$15.8M
Predoctoral Training Program in Human GeneticsT32GM007814 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI VALLE, DAVID · 1985 to 2021
$10.6M
NICHD NIH HHS HD024061NICHD NIH HHS P30 HD024061NIGMS NIH HHS T32 GM007814
6 · The paper itself

Abstract

Partial monosomy 21 was recently segregated into three regions associated with variable clinical severity. We describe 10 new patients, all examined by single nucleotide polymorphism (SNP) genotyping and G-banded karyotyping. Cohort A consisted of three patients seen in our medical genetics clinics with partial chromosome 21 monosomies. In two of these patients having terminal deletions (21q22.2-ter and 21q22.3-ter), the breakpoints differed by at least 812 Kb of sequence, containing seven RefSeq genes. A third patient had an interstitial hemizygous loss of 16.4 Mb (21q21.1-q22.11). All three patients had relatively mild phenotypes. Cohort B consisted of seven patients with partial chromosome 21 monosomies who had a greater number of dysmorphic features and some major malformations; SNP genotypes were obtained from the Coriell Genetic Cell Repository. We also collected data on partial monsomy 21 cases from the DECIPHER database. This report of 10 new cases of 21q deletion and review of a total of 36 confirms that deletion of the terminal region is associated with a mild phenotype, but suggests that deletion of regions 1 and 2 is compatible with life and have a variable phenotype perhaps relating more to other genetic and environmental variables than to genes in the interval.

Indexed as

Chromosome DeletionChromosomes, Human, Pair 21Developmental DisabilitiesGenotypeHumansIntellectual DisabilityKaryotypingMonosomyPhenotypePolymorphism, Single Nucleotide

Identifiers

PMID20823914
PMCPMC3025784

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.